title: Urodynamic alterations after prostatectomy in dogs without clinical prostatic disease.
abstract: Prostatectomy in dogs with clinical prostatic disease has been associated with a high incidence of urinary incontinence. In this study, urodynamic alterations after prostatectomy in 10 dogs without clinical prostatic disease were evaluated. Measurements of residual urine volume, simultaneous urethral pressure profilometry and electromyography, and carbon dioxide cystometry were made before and 14 and 20 weeks after prostatectomy. Voiding was observed daily for 20 weeks after prostatectomy. All dogs remained continent for 20 weeks after prostatectomy, and only minor urodynamic abnormalities were noted. Castration had no effect on urodynamic changes associated with prostatectomy. Prostatectomy produced minimal functional changes in dogs without clinical prostatic disease.
mesh_terms: D000818:Animals; D004283:Dog Diseases / Q000209:etiology / Q000503:physiopathology*; D004285:Dogs; D004576:Electromyography; D008297:Male; D009919:Orchiectomy / Q000662:veterinary; D011312:Pressure; D011468:Prostatectomy / Q000009:adverse effects / Q000662:veterinary*; D014521:Urethra / Q000473:pathology / Q000503:physiopathology; D001743:Urinary Bladder / Q000473:pathology / Q000503:physiopathology; D014549:Urinary Incontinence / Q000209:etiology / Q000503:physiopathology / Q000662:veterinary*; D014552:Urinary Tract Infections / Q000209:etiology / Q000662:veterinary; D014554:Urination; D014555:Urination Disorders / Q000209:etiology / Q000503:physiopathology / Q000662:veterinary*; D014556:Urine; D014563:Urodynamics; D014991:Xylazine / Q000494:pharmacology
chemical_list: D014991:Xylazine